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Saphenous vein graft occlusion is a common late complication of coronary 
bypass grafting. Intimal smooth muscle cell hyperplasia is a component of 
this pathobiology, but the underlying molecular events are poorly under- 
stood. Immediate-early genes are activated shortly after growth stimulation 
and subserve cellular functions, which may contribute to intimal smooth 
muscle cell accumulation. In the present study, human saphenous vein 
grafts were harvested with minimal manipulation during coronary bypass 
and processed for isolation of total ribonucleic acid to examine changes in 
immediate-early gene expression of messenger ribonucleic acid by Northern 
blotting techniques. Thirty saphenous vein grafts were incubated at 4 ~ C in 
Dulbecco's modified Eagle media from 30 minutes to 10 hours. The 
messenger ribonucleic acids for immediate-early genes c-fos and c-myc were 
weak or undetectable in controls but were increased (>10 times controls) 
within I hour (c-fos) and persisted for at least 6 hours (c.myc) after harvest. 
Our results demonstrate, for the first time in human vascular tissue, 
incipient immediate-early gene induction. This information may lead to 
molecular therapies to control saphenous vein graft disease. (J THORAC 
CARDIOVASC SURG 1995;110:209-13) 
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T he mechanisms leading to saphenous vein graft occlusion, and atherosclerosis n general, are 
complex. Important events include vascular injury, 
reactivity of circulating cells and lipoproteins, re -~ 
modeling of the extracellular matrix, and smooth 
muscle migration and hyperplasiaJ Migration of 
smooth muscle cells (SMCs) may be stimulated by 
platelet-derived growth factor from circulating cells 2 
or from other factors released from the vessel wall) 
Proliferation of SMCs appears to initially involve 
the modulation or dedifferentiation f cells from an 
"adult" contractile phenotype to that which resem- 
bles an embryonic "synthetic" proliferative pheno- 
type. 4 SMC hyperplasia can be accelerated by en- 
dothelial loss, which may occur during surgical 
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harvesting and manipulation of saphenous vein con- 
duits, s-7 This growth may also occur in the vessel 
wall with an intact endothelial barrier, s Both me- 
chanical and humoral factors activate various 
growth-related genes in SMCsJ Included among 
these genes are immediate-early genes, genes that 
are activated within minutes to hours of stimula- 
tion. 9 Animal studies have demonstrated the rapid 
induction of immediate-early genes after intimal 
injury from balloon deendothelial izationJ ~ Our 
present study seeks to demonstrate induction of 
messenger ribonucleic acid (RNA) of two imme- 
diate-early genes, c-los and c-myc, in human sa- 
phenous veins removed at the time of coronary 
artery bypass grafting. 
Methods 
Saphenous vein graft preparation. Segments of saphe- 
nous vein grafts were obtained at the time of vein harvest- 
ing during coronary artery bypass grafting, according to a 
protocol approved by the Internal Review Boards of New 
York Medical College and the Westchester County Med- 
ical Center. The vein segments (2 to 5 cm in length) were 
harvested with minimal manipulation and no distention. 
After the vessel was gently rinsed in physiologic saline 
solution, the control, "time zero," segments were snap- 
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frozen in liquid nitrogen. In the case of experimental 
segments, the rinsed vessel was placed in a Petri dish 
containing sterile Dulbecco's minimally modified Eagle's 
medium (DMEM; GIBCO-BRL, Gaithersburg, Md.) and 
incubated at 4~ for various times before the vein was 
frozen in liquid nitrogen. The time points studied after 
vein excision were 30 minutes and 1, 2, 4, 6, 8, and 10 
hours. Because of the limited amount of material avail- 
able from a single patient, each time point represents 
material from a different patient. RNA samples from four 
to six different patients were collected for the time zero 
through 6-hour points; thigh segments from two different 
patients were divided in half for the 8-hour and 10-hour 
time points. In several cases, a large tissue sample was cut 
in half so that two time points could be studied. Vein 
specimens were obtained for this study from five women 
(age range 49 to 79 years) and 21 men (mean 69 years, 
range 31 to 80 years). Twenty vessel segments were 
harvested from the thigh (17 men; 3 women) and six from 
the calf. 
Isolation of RNA and Northern blotting. Total RNA 
was isolated as previously described 1~ according to 
method of Chirgwin and associates. 13Control and exper- 
imental vein segments were removed from the liquid 
nitrogen and disrupted by homogenization (Polytron ho- 
mogenizer; Brinkman Instruments, Westbury, N.Y.) in 
guanidine thiocyanate 4 mol/L (Boehringer Mannheim; 
Indianapolis, Ind.) containing 2% /3-mercaptoethanol. 
After addition of N-lauroylsarcosine (0.5%; Fluka, 
Ronkonkoma, N.Y.), homogenates were sheared three 
times through a 23-gauge needle and clarified by centrif- 
ugation (10 ~ C, 10,000 g, 10 minutes). The resulting 
supernatants were layered over a cushion of cesium 
chloride 5.7 mol/L (Boehringer Mannheim) and RNA was 
pelleted by centrifugation. 14 Equivalent amounts of total 
RNA (15 /~g/lane) were separated on formaldehyde- 
containing 1% agarose gels. After electrophoresis, com- 
parable RNA loading between gel samples was verified by 
visualizing the ethidium bromide-stained gel under ultra- 
violet illumination. Lack of RNA degradation in all 
samples was also confirmed by the greater staining inten- 
sity of the 28S as compared with the 18Sribosomal RNA. 
The RNA was transferred onto a nylon membrane 
(BioRad Zeta-probe; Rockville Centre, N.Y.) by an over- 
night capillary transfer as described.10 After ultraviolet 
crosslinking (Stratagene; La Jolla, Calif.) of the RNA to 
the membrane, blots were hybridized with radiolabeled 
probes as described, m' al Complementary deoxyribonu- 
cleic acid (DNA) probes were labeled to a specific activity 
of 109 cpm//xg by random priming (Ambion, Austin, Tex.). 
Blots were washed at 55 ~ C for 30 minutes each m in 2• 
sodium chloride/sodium citrate (SSC)/I% sodium dode- 
cylsulfate (SDS), 1• SSC/0.5% SDS and 0.5• SSC/0.25% 
SDS, then exposed to Kodak XAR-5 x-ray film in the 
presence of enhancing screens at -80 ~ C for 1 day (c-los 
and glyceraldehyde-3-phosphodehydrogenase) to 7 days 
(c-myc). Unless replicate blots were prepared, the weakest 
probe was used first (e.g., c-myc); then blots were stripped 
and reprobed with additional cDNAs. Glyceraldehyde-3- 
phosphodehydrogenase served as a reference gene to 
normalize for RNA loading and transfer efficiency in all 
blots. Autoradiographic signals of mRNA levels on light 
film exposures were quantified by scanning densitometry 
on an LKB Ultrascan scanner (LKB Instruments, Inc., 
Rockville, Md.) as described and normalized with that of 
glyceraldehyde-3-phosphodehydrogenase. 1~ Eleven dif- 
ferent Northern blots were prepared; three were repli- 
cates of the majority of respective time points containing 
the same patients' RNA (i.e., blots 16 = 17 = 18 or 11 = 
12). Replicate blots served to confirm relative mRNA 
signals as a function of time. 
eDNA probes. The murine c-los probe was a 1.8 kb 
EcoRI-Sall fragment kindly provided by Dr; T. Curran 
(Roche Institute of Molecular Biology, Nutley, N.J.). The 
human third exon c-myc probe was from Oncor (Gaithers- 
burg, Md.) and human glyceraldehyde-3-phosphodehydro- 
genase 1.1 kb probe was from Clonetech (Palo Alto, Calif.). 
Results 
Fig. 1 illustrates the induction of c-fos mRNA in 
human saphenous vein grafts at several times after 
vessel excision and subsequent incubation of the 
vessel in cold DMEM (Methods). In one of the 
control (time zero) vessels (Fig. 1), trace levels of 
c-fos were detected by Northern blots of total saphe- 
nous vein graft RNA. The most robust (10 to 
100-fold) and consistent elevations in this immedi- 
ate-early gene were observed between 30 minutes 
and 2 hours; these levels tended to decrease be- 
tween 4 and 6 hours. In two patients a strong signal 
was also observed at 8 and 10 hours. The changes in 
c-fos levels cannot be explained by differential RNA 
loading efficiency because the level of glyceralde- 
hyde-3-phosphodehydrogenase, a reference mRNA, 
was comparable among all samples. 
Fig. 2 demonstrates mRNA levels for c-myc in 
saphenous vein graft segments as a function of time 
after excision. Two identical blots previously illus- 
ti:ated in Fig. 1 for c-los expression were also probed 
for c-myc; a third blot is a replicate containing the 
same patient's saphenous vein graft RNA. The 
pattern of c-myc expression differed somewhat from 
that of c-los in that trace to moderate signals were 
observed in all four zero-time samples and in three 
of four 30-minute samples (cf. blot 10, Fig. 1 versus 
Fig. 2). Like c-los, c-myc expression was prominent 
in less than 2 hours and later at 8 to 10 hours. Unlike 
c-los, a c-myc signal was obvious at 6 hours. The 
pattern of these results, of differential immediate- 
early gene signals as a function of time, was not 
obviously correlated with saphenous vein source (leg 
versus thigh) or with patient age or gender. 
Discussion 
Animal studies have demonstrated induction of 
c-fos and c-myc expression in rat or rabbit aortas 
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Fig. 1. Northern blots of c-fos mRNA expression in total RNA isolated from human saphenous veins. 
Vessels were excised and either immediately frozen in liquid nitrogen (time zero) or incubated at 4 ~ C in 
DMEM for the indicated times before freezing the tissue. Total saphenous vein graft RNA was isolated by 
cesium chloride centrifugation and 15 /xg of RNA was separated on agarose gels for transfer to nylon 
membranes (blots). The blots were hybridized with a murine probe for c-los or human glyceraldehyde-3- 
phosphodehydrogenase (GAPDH) (#16); The size of the c-fos human mRNA detected was about 2.2 kb. 
(Although not shown here, blots #10 and 14 were also probed for GAPDH with results similar to those of 
blot #16.) One-day film exposures of three representative blots are illustrated. Patient characteristics for 
each blot are as follows for #10, #14, and #16, respectively (F, female, M, male, T, thigh, L, leg). Control 
time zero: F56T, M54L, M80T/F50T; 0.5 hour, M66L, M66L, FSOT; 1 hour, M77T, M63T, FSOT; 2 hour, 
M77T, M63T, M63T; 4 hour, M45T, M45T, M62T; 6 hour, M45T, F49L, M62T; 8 hour and 10 hour (blot 
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Fig. 2. Northern blots of c-myc mRNA expression in total RNA isolated from human saphenous veins. A 
human c-myc eDNA was used to detect c-myc mRNA (about 2.5 kb). Patient characteristics are indicated 
in the legend to Fig. 1 because blot #18 contains the replicate 15/xg RNA samples of those used in #16. 
This blot was also probed with glyceraldehyde-3-phosphodehydrogenase to confirm comparable RNA 
loading as in blot #16 (data not shown). 
after balloon deendothelialization, mq2 In either 
model, these mRNAs increase within 15 to 30 
minutes (c-los) to 2 hours (c-myc) after vascular 
injury, and the protein products are detectable in rat 
medial SMCs by 2 hours, a5 These events precede 
SMC hyperplasia, ~ and there is substantial evidence 
from in vitro cell culture studies that these immedi- 
ate-early genes play key roles in the proliferative 
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process.16,17 This report demonstrates, for the first 
time, induction of these genes directly from in vivo 
human vascular tissue before the onset of intimal 
SMC proliferation. This study does not localize the 
gene response to the smooth muscle or endothelium 
of the vein, because the entire vein was processed. 
Our previous animal work, however, has localized 
these genes in the smooth muscle layer of the 
aorta.10, is
Immediate-early genes are defined as genes 
whose transcripts are transiently increased early 
after growth factor stimulation without requisite 
protein synthesis. 9 The products of immediate-early 
genes presumably subserve protean functions within 
the cell related to growth and differentiation, asin 
the case of c-fos. The immediate-early gene c-fos is 
a transcription factor which, in a heterodimeric 
complex with members of the c-jun family, binds to 
and activates AP-1 sites in the promoters of genes. 9 
In the case of SMC growth responses after vascular 
injury, 1 the activation of c-fos could lead to activa- 
tion of growth factors uch as transforming growth 
factor/31.16 In neural systems, c-los is rapidly acti- 
vated by cellular depolarization r ischemia. 9 
The transcription factor c-myc seems to be more 
closely linked to cell proliferation than to differen- 
tiation. Various human cancers, including hemato- 
logic malignancies, exhibit elevated expression of 
the c-myc gene. 17 When various growth-quiescent 
cell lines are stimulated with serum or growth 
factors, c-myc expression is enhanced and precedes 
DNA synthesis,  
The demonstration of these immediate-early 
genes in human vascular tissue is not unexpected, 
given their presence in many cells. With the lack of 
other tissue as  a control, it is possible that the 
immediate-early gene response may be part of a 
total body response to trauma. Further', these results 
are semiquantitative, given the limited number of 
samples and the use of different patients for each 
time point. Signal strength, however, is increased 
approximately 100-fold from barely detectable con- 
trol levels to maximum exposure. The activation of 
these genes, however, was initiated by minimal gross 
disturbance of the tissue itself. The saphenous veins 
were freshly harvested, not flushed, distended, or 
manipulated in any manner common to preparation 
of veins for coronary artery bypass grafting. "Exces- 
sive" manipulation and nonphysiologic distention of 
vein grafts leads to greater endothelial loss and 
consequent acceleration of SMC hyperplasia, s'7
This may explain the positive signals in the "time 
zero" control vessels. The temperature and DMEM 
incubation media may also have some secondary 
effect on the expression of immediate-early genes, 
because the time frame for the activation of these 
genes is consistent with parallel manipulations of
the rat thoracic aorta (results not shown; R. A. 
Moggio, J. Ding and C. J. Smith, preliminary data). 
A possible implication of our study is that even 
the most meticulous process of preparing and "ar- 
terializing" avein segment isa sufficient stimulus to 
activate growth-related genes. Whether this physical 
manipulation 1~in concert with humoral factors uch 
as platelet-derived growth factor 19 or other mito- 
gens leads to a synergistic SMC growth response is 
unclear. The relative importance of SMC prolifera- 
tion and secretion and extracellular matrix forma- 
tion and scarring in human atherosclerotic processes 
is also unknown. 2~ The results reported here, how- 
ever, are consistent with the hypothesis that early 
induction of the immediate-early genes c-los and 
c-myc in human SMCs may be part of a pathway that 
leads to intimal hyperplasia. Further elucidation of 
these mechanisms may lead to more fundamental 
therapeutic strategies to limit the early atherogenic 
response. 
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Discussion 
Dr. Andrew S. Wechsler (Richmond, Va.). Did you 
consider doing something like in situ hybridization to see 
if you could figure out which cell moieties were responsi- 
ble for the immediate-early gene response? 
Dr. Moggio. We do not have that technique for human 
tissue. In related histochemical techniques we have iden- 
tified these proteins in the medial SMC layer of the rat 
aorta after injury. In a second experiment we have made 
a medial SMC-enriched preparation by removal of adven- 
titial tissue and have demonstrated the mRNA precursor 
of the protein products. 
Dr. Pedro J. del Nido (Pittsburgh, Pa.). Correct me if I 
am wrong, but it is my understanding that one of the early 
triggers to this early gene expression is protein kinase C 
activation or translocation, and there are ways to inhibit 
that. Wouldn't it be simpler to tackle the early transduc- 
tion signal rather than trying to inject or prevent new gene 
expression? Do you have any information about the early 
signal transduction? 
Dr. Moggio. This study did not look at this system, but 
we do have preliminary data in a rat aortic preparation 
that inhibition of  protein kinase C can prevent some 
balloon injury induced expression Of c-los and other 
immediate-early genes. However, most inhibitors that we 
have used are not specific for selected PK isoforms, such 
as the zeta form. 
Dr. John C. Alexander (Evanston, Ill.). This paper 
shows a genetic reason for some of the things that we see 
in bypass grafts. 
Did you use a pulse duplicator model in this study? I
have made the clinical observation, as have many others, 
that atherosclerosis n vein grafts seems to surround 
valves. The pressure changes that can be seen in associa- 
tion with bypass grafts and valves may be an  interesting 
local area of this gene expression leading to atherosclero- 
sis and thrombosis. 
Dr. Moggio. I think that is possible. We have not 
examined endothelial changes or pulsatile flow situations, 
but these genes are quite sensitive to mechanical and 
stretch stimuli. 
Our technique requires the maintenance ofhigh-quality 
mRNA, which we preserve in vitro with buffer solution. 
Careful incubation and processing are required to bring 
out the RNA signal. Cells not preserved in this manner 
will start to die and the mRNA will begin to deteriorate. 
Dr. Andrew S. Weehsler (Richmond, Va.). These early 
genes are sometimes just a manifestation of tissue re-' 
sponse to injury. Would you accept that as another 
possibility, that it isn't really a precurso r to development? 
Dr. Moggio. That is possible because the amount of 
manipulation to the vein was minimal, much less that is 
done during meticulous vein graft harvest and prepara- 
tion. We are continuing to examine whether later genes 
that are stimulated are more predictive of cellular prolif- 
eration. 
